I suppose its a good thing they are letting others do the exploratory trials on their own dime (and not GERN's), however, this calls into the question some analysts brought up on the call: so, what exactly are these guys getting paid several hundreds of thousands of dollars in salaries to do, for the next 12 months?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.